BIO Commends Senate for Approval of User Fee Package – Marketwatch
WASHINGTON, Jun 26, 2012 (BUSINESS WIRE) -- Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood released the following statement on passage of S. 3187, the Food and Drug Administration Safety and Innovation Act (FDASIA), by ...
Subscribe to LegalLaw247.Com Newsletter